Published in Br J Anaesth on July 26, 2004
Comparison of aprotinin and tranexamic acid in adult scoliosis correction surgery. Eur Spine J (2012) 0.85
Bronchoscopic intratumoral injection of tranexamic acid to prevent excessive bleeding during multiple forceps biopsies of lesions with a high risk of bleeding: a prospective case series. BMC Cancer (2014) 0.80
Recombinant activated factor VII (Novo7) in patients with ventricular assist devices: case report and review of the current literature. J Cardiothorac Surg (2007) 0.79
Introducing DInaMo: A Package for Calculating Protein Circular Dichroism Using Classical Electromagnetic Theory. Int J Mol Sci (2015) 0.78
The prophylactic role of tranexamic acid to reduce blood loss during radical surgery: A prospective study. Anesth Essays Res (2015) 0.77
A case report and brief review of the literature on bilateral retinal infarction following cardiopulmonary bypass for coronary artery bypass grafting. J Cardiothorac Surg (2011) 0.76
Perioperative tranexamic acid in day-case paediatric tonsillectomy. Ann R Coll Surg Engl (2014) 0.75
Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med (1999) 4.63
The effect of anticoagulant choice on apparent total antioxidant capacity using three different methods. Ann Clin Biochem (1995) 3.10
The laryngeal mask airway. A study of 100 patients during spontaneous breathing. Anaesthesia (1989) 2.76
HIT/HITT and alternative anticoagulation: current concepts. Br J Anaesth (2003) 2.76
The anaesthetist as peri-operative physician. Anaesthesia (2000) 2.68
Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med (1995) 2.52
Efficacy of dexmedetomidine compared with midazolam for sedation in adult intensive care patients: a systematic review. Br J Anaesth (2013) 2.17
Pulmonary aspiration of gastric contents in anaesthesia. Br J Anaesth (1999) 1.82
Oxidative stress and gene expression in sepsis. Br J Anaesth (2003) 1.64
Matrix metalloproteinase-9 concentrations in critically ill patients. Anaesthesia (2001) 1.60
Sepsis and the systemic inflammatory response syndrome. J R Coll Surg Edinb (2000) 1.58
Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis. Crit Care Med (1997) 1.49
Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med (1996) 1.48
Altered cardiac function. J R Coll Surg Edinb (2001) 1.45
Use of inhaled nitric oxide in British intensive therapy units. Br J Anaesth (1997) 1.41
The influence of surgery on the onset of symptomatic coronary artery disease. Anaesthesia (2012) 1.40
Poor response to oral ciprofloxacin in the treatment of peritonitis in patients on intermittent peritoneal dialysis. Perit Dial Int (1993) 1.40
Exhaled nitric oxide as a marker of lung injury in coronary artery bypass surgery. Br J Anaesth (2002) 1.39
Physiology of the endothelium. Br J Anaesth (2004) 1.25
The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth (1992) 1.17
Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study. Crit Care Med (1994) 1.16
Elevated serum bleomycin-detectable iron concentrations in patients with sepsis syndrome. Intensive Care Med (1996) 1.13
Increased nuclear factor kappa B activation in critically ill patients who die. Crit Care Med (2000) 1.10
Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. Free Radic Biol Med (1996) 1.09
T helper cell subset ratios in patients with severe sepsis. Intensive Care Med (1999) 1.08
Cytokines and the immunomodulatory function of the vagus nerve. Br J Anaesth (2009) 1.07
Free radicals and antioxidants in sepsis. Crit Care Med (1993) 1.06
The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med (1997) 1.05
Combination oral antioxidant supplementation reduces blood pressure. Clin Sci (Lond) (1997) 1.03
Genotype and interleukin-10 responses after cardiopulmonary bypass. Br J Anaesth (2003) 1.02
The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes. Anesth Analg (1998) 1.02
UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS. Intensive Care Med (1997) 1.01
Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. Br J Anaesth (2013) 1.00
Role of microparticles in sepsis. Br J Anaesth (2012) 0.97
Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med (1996) 0.97
Nitric oxide synthase activity is increased in patients with sepsis syndrome. Clin Sci (Lond) (1995) 0.97
Differential modulation of interleukin-6 and interleukin-10 by diclofenac in patients undergoing major surgery. Br J Anaesth (2002) 0.96
Reperfusion injury, antioxidants and hemodynamics during orthotopic liver transplantation. Hepatology (1994) 0.96
Auditory evoked response and awareness: a study in volunteers at sub-MAC concentrations of isoflurane. Br J Anaesth (1992) 0.95
The effect of nitric oxide and peroxynitrite on apoptosis in human polymorphonuclear leukocytes. Free Radic Biol Med (1998) 0.94
Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis. Crit Care Med (2000) 0.92
The immuno-inflammatory cascade. Br J Anaesth (1996) 0.92
Time course of changes in lung permeability and edema in the rat exposed to 100% oxygen. J Appl Physiol (1985) (1990) 0.92
Direct detection of free radical generation in an in vivo model of acute lung injury. Free Radic Res Commun (1991) 0.90
Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndrome. Br J Anaesth (1996) 0.90
Immunomodulation by anaesthetic, sedative and analgesic agents: does it matter? Intensive Care Med (2000) 0.88
Activated protein C inhibits chemotaxis and interleukin-6 release by human neutrophils without affecting other neutrophil functions. Br J Anaesth (2008) 0.86
Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and tumour necrosis factor alpha release during cardiopulmonary bypass. Anaesthesia (2002) 0.85
Spinal but not general anesthesia increases the ratio of T helper 1 to T helper 2 cell subsets in patients undergoing transurethral resection of the prostate. Anesth Analg (1998) 0.85
Regulation of pentraxin-3 by antioxidants. Br J Anaesth (2009) 0.84
Inhibition of neuronal nitric oxide synthase reduces isoflurane MAC and motor activity even in nNOS knockout mice. Br J Anaesth (2006) 0.84
Effect of ciprofloxacin on the activation of the transcription factors nuclear factor kappaB, activator protein-1 and nuclear factor-interleukin-6, and interleukin-6 and interleukin-8 mRNA expression in a human endothelial cell line. Clin Sci (Lond) (2000) 0.83
Acute lung injury in fulminant hepatic failure following paracetamol poisoning. Thorax (1995) 0.83
Melatonin and structurally similar compounds have differing effects on inflammation and mitochondrial function in endothelial cells under conditions mimicking sepsis. Br J Anaesth (2011) 0.82
Nitric oxide synthase activity is increased in relation to the severity of liver dysfunction. Clin Sci (Lond) (1998) 0.82
Circulating tetrahydrobiopterin concentrations in patients with septic shock. Br J Anaesth (2001) 0.81
Central venous line sepsis in the intensive care unit. A study comparing antibiotic coated catheters with plain catheters. Anaesthesia (1996) 0.81
Mitochondrial redox state in the critically ill. Br J Anaesth (1999) 0.81
The role of the intensive care unit in the management of the critically ill surgical patient. J R Coll Surg Edinb (1999) 0.81
The effects of nitric oxide and peroxynitrite on interleukin-8 and elastase from lipopolysaccharide-stimulated whole blood. Anesth Analg (1998) 0.81
Differential nitric oxide synthase activity, cofactor availability and cGMP accumulation in the central nervous system during anaesthesia. Br J Anaesth (2001) 0.81
Variability in E-selectin expression, mRNA levels and sE-selectin release between endothelial cell lines and primary endothelial cells. Cell Biol Int (2000) 0.81
Alterations in plasma magnesium concentrations during liver transplantation. Transplantation (1993) 0.81
Mediators of fibrinolysis in orthotopic liver transplantation. Clin Transplant (1996) 0.81
Nitric oxide production by human peripheral blood polymorphonuclear leucocytes. Clin Sci (Lond) (1994) 0.80
Tissue responses to hyperoxia. Biochemistry and pathology. Br J Anaesth (1987) 0.80
Levels of consciousness in volunteers breathing sub-MAC concentrations of isoflurane. Br J Anaesth (1990) 0.79
Halothane hepatitis patients generate an antibody response toward a covalently bound metabolite of halothane. Anesthesiology (1988) 0.79
Regulation of nitric oxide synthase activity in cultured human endothelial cells: effect of antioxidants. Free Radic Biol Med (1996) 0.78
Brain nitric oxide synthase activity is decreased by intravenous anesthetics. Anesth Analg (1996) 0.78
Changes in inflammatory mediators during orthotopic liver transplantation. Br J Anaesth (1997) 0.78
Anaesthetic agents decrease the activity of nitric oxide synthase from human polymorphonuclear leucocytes. Br J Anaesth (1995) 0.78
Effect of inhaled nitric oxide on key mediators of the inflammatory response in patients with acute lung injury. Crit Care Med (2000) 0.77
The role of the microcirculation in the multi-organ dysfunction syndrome. Clin Intensive Care (1994) 0.77
Effect of the nitric oxide inhibitor, L-N(G)-monomethylarginine, on accumulation of interleukin-6 and interleukin-8, and nuclear factor-kappaB activity in a human endothelial cell line. Crit Care Med (1999) 0.76
Bibliometrics and assessing performance and worth. Br J Anaesth (2011) 0.76
Cardiac function during orthotopic liver transplantation with venovenous bypass. Anaesthesia (1995) 0.76
Total antioxidant capacity and lipid peroxidation during liver transplantation. Clin Sci (Lond) (1995) 0.76
Consider position of patient to prevent ventilator-associated pneumonia. Anaesthesia (2000) 0.75
Free radical detoxifying systems in human colorectal cancer. Br J Cancer (1985) 0.75
Sepsis and the systemic inflammatory response syndrome. J R Coll Surg Edinb (2000) 0.75
Adverse reaction to disopyramide. Postgrad Med J (1979) 0.75
Inhaled nitric oxide. Lancet (1996) 0.75
Effects of propofol and thiopentone on the immune response. Anaesthesia (1997) 0.75
Evidence based practice in intensive care--light on the horizon? Br J Anaesth (2001) 0.75
Flow cytometry. Br J Anaesth (1997) 0.75
Does strict glucose control improve outcome? Br J Anaesth (2009) 0.75
Emerging modes of ventilation in the intensive care unit. Br J Anaesth (2011) 0.75
Inotropic agents in the critically ill. Br J Hosp Med (1997) 0.75
Stranger danger-mortality after transfusions. Br J Anaesth (2017) 0.75
Why is the patient still hypoxic despite being ventilated? J R Coll Surg Edinb (2000) 0.75
Inhibition of neuronal nitric oxide synthase reduces the propofol requirements in wild-type and nNOS knockout mice. Eur J Anaesthesiol (2006) 0.75
The 2011 BJA/PGA supplement: a selection of nine educational reviews. Br J Anaesth (2011) 0.75
Effects of blood storage on red cell antioxidative systems. Acta Haematol (1986) 0.75
Hyperoxia and salicylate metabolism in rats. J Pharm Pharmacol (1990) 0.75
Inorganic phosphate transport across the red blood cell membrane: the effect of exposure to hyperoxia. Clin Chim Acta (1987) 0.75
Professors live longer than doctors: immortality bias in survival analysis. Br J Anaesth (2011) 0.75
Nitric oxide in critical care medicine. Br J Hosp Med (1996) 0.75
Sleep and comfort after caesarean section. Anaesthesia (1986) 0.75
Tumours of the glomus jugulare. Case report and anaesthetic management for the combined two stage operation. Anaesthesia (1986) 0.75